| Labatec Pharma SA - Dorzolamide/Timolol Labatec 20.0 mg/ml, 5.0 mg/ml, collyre en solution | | 68596 | | 01 | | Dorzolamide/Timolol Labatec 20.0 mg/ml, 5.0 mg/ml | | collyre en solution | | S01ED51 | | Timolol, Combinations | | 07.07.2022 | | |
| | Composition | | dorzolamidum 20 mg ut dorzolamidi hydrochloridum 22.26 mg, timololum 5 mg ut timololi maleas 6.83 mg, benzalkonii chloridum 75 µg, natrii citras dihydricus, hydroxyethylcellulosum, natrii hydroxidum, mannitolum, aqua ad iniectabile ad solutionem pro 1 ml. | | Packungsbestandteile | | collyre en solution | | | | | | Active Agent | Dose |
|---|
| Dorzolamide | 20 mg/ml | | Timolol | 5 mg/ml |
| | | | Inactive agents | Dose |
|---|
| Benzalkonium Chloride | 75 µg/ml | | Hydroxyethylcellulosum | | | Mannitol | | | Natrii Citras Dihydricus | | | Sodium Hydroxide | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 5 ml | PR | PR | B | | Yes |
|
|
